InfuSystem Holdings (INFU) EBT Margin Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 423.00 |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 857.00 |
| Mar 31, 2026 | 618.00 |
| Dec 31, 2025 | 782.00 |
| Sep 30, 2025 | 739.00 |
| Jun 30, 2025 | 995.00 |
| Mar 31, 2025 | 397.00 |
| Dec 31, 2024 | 254.00 |
| Sep 30, 2024 | 1,039.00 |
| Jun 30, 2024 | 248.00 |
| Mar 31, 2024 | -603.00 |
| Dec 31, 2023 | -83.00 |
| Sep 30, 2023 | -834.00 |
| Jun 30, 2023 | -1,403.00 |
| Mar 31, 2023 | -17.00 |
| Dec 31, 2022 | -186.00 |
| Sep 30, 2022 | -341.00 |
| Jun 30, 2022 | -276.00 |
| Mar 31, 2022 | 185.00 |
| Dec 31, 2021 | 602.00 |
| Sep 30, 2021 | 34.00 |